http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA06006955-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caec7099b724bb45d2518787825aab94
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
filingDate 2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c77bb894023eaa6b182892489171125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71b6f089ed548f754242e5c22fb3f62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec2d04e6f3f77019c9888371d93968a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f440223652e593ea7fd6b77680c6a61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2147a2cf768d805608863bf890a12916
publicationDate 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA06006955-A
titleOfInvention NEW OXAZOLIDINONE DERIVATIVES.
abstract The present invention relates to novel oxazolidinone derivatives, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have excellent efficiency in their solubility against water. In addition, derivatives of the present invention can exert potent antibacterial activity against various pathogens of humans and animals, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, compositions comprising oxazolidinone are used in an antibiotic.
priorityDate 2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23420811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949

Total number of triples: 39.